Besremi subcutaneous injection 250μg syringe, from Pharma Essentia Japan, contains Ropeg interferon alpha-2b (genetical recombination). This pegylated interferon is used to treat certain myeloproliferative neoplasms. It is provided as 250μg in 0.5mL per tube, with YJ code 4291467G1021.
Besremi subcutaneous injection 250μg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →